Lung Innate COVID-19 Defense Specific to Veterans Risk Characteristics
针对退伍军人风险特征的肺部先天性 COVID-19 防御
基本信息
- 批准号:10359086
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVACE2AddressAffectAgeAgingAlcohol abuseAlcoholsAlveolar MacrophagesAlveolusBindingCOVID-19COVID-19 mortalityCOVID-19 pandemicCOVID-19 riskCellsCessation of lifeCharacteristicsChronic Obstructive Pulmonary DiseaseChronic lung diseaseCiliaClinicalCollectinsCommunitiesContractsCoronavirusCoronavirus InfectionsCoronavirus spike proteinCountryDataDefense MechanismsDefensinsDiseaseElderlyEnzymesEpidemiologyEpithelial CellsFunctional disorderFutureGRP78 geneGeneral PopulationHealthHumanImmuneImpairmentIndividualInfectionInnate Immune SystemKnowledgeLeadLungLung diseasesMedicalModalityMucociliary ClearanceMucous body substanceNatural ImmunityOutcomePatientsPersonsPhysiciansPopulationPredisposing FactorPredispositionPreventive careProcessProteinsPulmonary Surfactant-Associated Protein DResearchResearch PersonnelResearch SupportRiskRisk FactorsRoleRouteSARS-CoV-2 infectionSARS-CoV-2 pathogenesisScientistSiteSmokingStructureSymptomsTestingTimeTissuesVeteransViralVirusVirus DiseasesVirus ReceptorsVulnerable PopulationsWorkWritingage effectairway epitheliumalcohol misusealcohol use disorderantimicrobialbasebiobankcareercigarette smokingexperiencehigh riskhigh risk populationhuman old age (65+)infection rateinjury and repairlung injurymacrophagemilitary veteranmortalitynovel coronaviruspandemic diseaseparticlepreventpulmonary functionreceptorreceptor functionresponseskillssurfactant
项目摘要
COVID-19 is now a global pandemic requiring a rapid and concerted response from the scientific and medical
community. Based upon recent epidemiology derived only months earlier from the earliest affected countries,
the pathogenesis of the SARS-CoV-2 virus and clinical outcomes from COVID-19 are far worse in individuals
with certain pre-existing conditions and those of advanced age. It is essential to the health of Veterans to fully
define which at-risk conditions particularly impact them and their unique needs and to do so immediately in
order to empower clinical preventive care during this and future viral pandemics. Compared to the general
public, the Veterans population can be characterized by older age, cigarette smoking leading to pre-existing
lung diseases such as chronic obstructive pulmonary disease (COPD), and alcohol use disorders (AUD). Our
knowledge about how such characteristics impact SARS-CoV-2 pathogenesis is limited. However, results from
our previous VA-supported research have already demonstrated that old age and AUD are associated with
cilia dysfunction. Our results also demonstrate that AUD results in decreased surfactant anti-microbial action.
Surfactant protein D has been documented to specifically bind to and neutralize the Spike protein of
coronavirus. We hypothesize that altered innate lung defense at the level of mucociliary clearance, anti-
microbial surfactants, and viral receptor function will negatively impact susceptibility and pathogenesis of
SARS-CoV-2, placing Veterans particularly in harm’s way. Our assembled team of investigators include a VA
Research Career Scientist with 25 years’ experience in the impact of alcohol on lung injury and repair, a
physician-scientist at the VA whose expertise is on the impact of age in lung function, and a microbiologist who
is already experienced in working with SARS-CoV-2 under BSL3 conditions. Combined with our existing
biobank of human lung cells and tissues, we propose to address our hypothesis by identifying any differences
in SARS-CoV-2 infection responses between normal airway epithelium and lung macrophages and those cells
collected from individuals with COPD, with AUD, or of old age. We will specifically identify in these groups any
changes in cilia beat controlling clearance, surfactant protein D expression/structure/function, and known
SARS-CoV-2 receptors. Such studies will be performed for the first time in these high-risk groups common to
the VA population. Defining the modalities of risk will empower clinicians to make informed clinical preventive
care decisions for Veterans.
COVID-19 现在是一种全球大流行病,需要科学和医学界做出快速、一致的反应
根据仅几个月前从最早受影响的国家得出的最新流行病学数据,
SARS-CoV-2 病毒的发病机制和 COVID-19 的临床结果在个体中要差得多
患有某些已有疾病和高龄的人,充分了解退伍军人的健康至关重要。
确定哪些高风险状况对他们及其独特需求特别影响,并立即这样做
与一般情况相比,在这次和未来的病毒大流行期间加强临床预防护理。
对于公众来说,退伍军人群体的特点是年龄较大、吸烟导致预先存在的
肺部疾病,例如慢性阻塞性肺病(COPD)和酒精使用障碍(AUD)。
然而,关于这些特征如何影响 SARS-CoV-2 发病机制的知识还很有限。
我们之前 VA 支持的研究已经证明,老年和 AUD 与
我们的结果还表明,AUD 会导致表面活性剂的抗菌作用降低。
表面活性剂蛋白 D 已被证明可以特异性结合并中和刺突蛋白
我们遭受了冠状病毒在粘液纤毛清除水平、抗病毒水平上的先天性肺部防御能力的改变。
微生物表面活性剂和病毒受体功能将对病毒的易感性和发病机制产生负面影响
SARS-CoV-2,使退伍军人尤其受到伤害。我们组建的调查团队中包括退伍军人管理局。
职业科学家,在酒精对肺损伤和修复的影响方面拥有 25 年经验,
退伍军人管理局的医师科学家,其专业知识是年龄对肺功能的影响,以及微生物学家
结合我们现有的条件,在 BSL3 条件下处理 SARS-CoV-2 已有经验。
人类肺细胞和组织的生物库,我们建议通过识别任何差异来解决我们的假设
正常气道上皮和肺巨噬细胞以及这些细胞之间的 SARS-CoV-2 感染反应
从患有慢性阻塞性肺病 (COPD)、澳元 (AUD) 或老年患者的个人中收集的数据,我们将在这些群体中特别识别出任何人。
纤毛跳动控制清除、表面活性剂蛋白 D 表达/结构/功能的变化,以及已知的
此类研究将首次在这些常见的高危人群中进行。
定义风险模式将有助于制定明智的临床预防措施。
退伍军人的护理决定。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Aldehyde Trapping by ADX-102 Is Protective against Cigarette Smoke and Alcohol Mediated Lung Cell Injury.
- DOI:10.3390/biom12030393
- 发表时间:2022-03-02
- 期刊:
- 影响因子:5.5
- 作者:Ochoa CA;Nissen CG;Mosley DD;Bauer CD;Jordan DL;Bailey KL;Wyatt TA
- 通讯作者:Wyatt TA
Synergistic Detrimental Effects of Cigarette Smoke, Alcohol, and SARS-CoV-2 in COPD Bronchial Epithelial Cells.
- DOI:10.3390/pathogens12030498
- 发表时间:2023-03-22
- 期刊:
- 影响因子:0
- 作者:Muralidharan A;Bauer CD;Katafiasz DM;Strah HM;Siddique A;Reid SP;Bailey KL;Wyatt TA
- 通讯作者:Wyatt TA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kristina L Bailey其他文献
Kristina L Bailey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kristina L Bailey', 18)}}的其他基金
Pulmonary aging increases MUC5AC in the airway epithelium, increasing the risk of carcinogenesis
肺部老化增加气道上皮中的MUC5AC,增加致癌风险
- 批准号:
10583805 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Lung Innate COVID-19 Defense Specific to Veterans Risk Characteristics
针对退伍军人风险特征的肺部先天性 COVID-19 防御
- 批准号:
10151991 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Biphasic alcohol regulation of TLR2 in airway epithelium
气道上皮 TLR2 的双相酒精调节
- 批准号:
8617198 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Biphasic alcohol regulation of TLR2 in airway epithelium
气道上皮 TLR2 的双相酒精调节
- 批准号:
8436337 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Biphasic alcohol regulation of TLR2 in airway epithelium
气道上皮 TLR2 的双相酒精调节
- 批准号:
8037205 - 财政年份:2010
- 资助金额:
-- - 项目类别:
相似国自然基金
感毒清经ACE2/Ang(1-7)/MasR信号通路抑制PM2.5诱导慢性气道炎症的机制:聚焦肺泡巨噬细胞极化与“胞葬”的表型串扰
- 批准号:82305171
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
- 批准号:82305216
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
- 批准号:32302080
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
刺参自溶引发机制中ACE2调控靶点的调控网络研究
- 批准号:32372399
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
- 批准号:82330111
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
相似海外基金
Potential role of skin in SARS-CoV-2 infection
皮肤在 SARS-CoV-2 感染中的潜在作用
- 批准号:
10593622 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Investigating the role and therapeutic potential of the alpha5beta1 integrin in risk factors for COVID-19-associated cognitive impairment
研究 α5β1 整合素在 COVID-19 相关认知障碍危险因素中的作用和治疗潜力
- 批准号:
10658178 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Vagal airway sensory nerve activation by beta-coronavirus spike protein
β-冠状病毒刺突蛋白激活迷走神经气道感觉神经
- 批准号:
10748485 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Chitin and chitinases in SARS-CoV-2 infection
SARS-CoV-2 感染中的几丁质和几丁质酶
- 批准号:
10742004 - 财政年份:2023
- 资助金额:
-- - 项目类别: